Organoid Technology and Clinical Applications in Digestive System Cancer

Xiaofang Zhao,Youhai Jiang,Chunliang Liu,Minghui Hou,Hongyang Wang,Jing Fu

DOI: https://doi.org/10.1016/j.eng.2021.04.017

IF: 12.834

2022-01-01

Engineering

Abstract:Cancers of the digestive system(DS),including esophageal,gastric,colorectal,liver,and pancreatic can-cers,have a high incidence and mortality worldwide.Current cancer models cannot faithfully recapitu-late the critical features of the original tumor,resulting in the failure of translation from basic research into clinical practice.More advanced cancer models are in urgent need of pathogenesis exploration and anticancer medicine development.Organoids are in vitro cultured three dimensional(3D)self-organizing organotypic structures derived from tissues and pluripotent stem cells,which faithfully mimic the histological features and preserve the genetic heterogeneity of the original tissues.Both normal and malignant organoids can now be efficiently established from the DS tissues of patients.In this review,we summarize the general methods to generate human DS organoids and their applications as a novel model in basic cancer research,preclinical medical practice,and precision medicine.